Xingchen Peng

53PUBLICATIONS
53CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Biomedical instrumentationTumour immunologyOral and maxillofacial surgery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Oct 05, 2026
Hypoxia-Regulating Nanozymes for Biomedicine.

|Sep 12, 2026
Neoadjuvant chemoimmunotherapy with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-2): an open-label, single-arm, phase 2 study.

|Sep 01, 2026
Study of Adaptive Radiotherapy for High-Grade Glioma Based on Interfraction MRI.

|Jul 21, 2026
Radiotherapy and tertiary lymphoid structures: balancing immune activation and immune damage in cancer immunotherapy.

|Jul 16, 2026
Oral Spermidine Supplementation Preserves Submandibular Gland Function After Radiotherapy: Mechanistic Insights and Use in a Phase II Randomized Clinical Trial.

|Jul 10, 2026
Beyond apoptosis: nanomedicine enabled reprogramming of tumor cell death for next-generation radiosensitization.

Pageof 9

Frequent Collaborators

8 joint publications

Zheran Liu

6 joint publications

Jingjing Wang

5 joint publications

Hui Guan

3 joint publications

Yiyan Pei